Ultralase

Ultralase

May 23, 2011 06:30 ET

Ultralase Outperforms the Industry in 2010

- The company gains more market share in tough trading conditions

- 99.1% of patients treated in 2010 achieved driving standard vision or better

- Early indications for 2011 show signs of promise

LEEDS, ENGLAND--(Marketwire - May 23, 2011) - The UK's longest established vision correction specialist, Ultralase, today announces strong trading results for the second year running.

With a five per cent growth in revenue to £42.3m for the full year, * compared to £40.3m in 2009, the company has continued to strengthen its position within the marketplace, stealing share from the competition.

Whilst economic conditions continue to be challenging, the company continues to buck the trend with sales up 8 per cent in its core refractive business.

Investment in clinical leadership and the capability of the wider team has continued to form a key part of Ultralase's growth strategy, contributing to an improved operational performance with 99.1 per cent of patients treated during 2010 achieving driving standard or better vision, compared to 98.2 per cent in 2009.

Furthermore, initial figures for 2011 look promising with NPD investments starting to add value, evidenced through increased revenue from the company's Intra Ocular Lens (IOL) business, up 70 per cent in the first quarter.

Tony Veverka, Chief Executive, Ultralase commented, "Whilst market conditions remain challenging, our latest figures are a clear indication that the Group continues to increase market share. Our performance year on year and in the context of our competitors remains strong and is testimony to our growth strategy and continued investment in our clinical team and advanced technology.

"Few if any other providers in our industry will be able to match our performance across the board, reporting increased revenue, increased treatment volumes, improved operational profit and growth through the clinic estate.

"As the UK's longest established vision correction specialist, 2011 sees us celebrate our 20th year and we are delighted that the outlook is promising. With 31 clinics in the UK and Ireland and a series of new clinic openings planned this year, we are well positioned to achieve further gains in market share within the industry."

Since its launch in 1991, with its first specialist clinic in the Wirral, Ultralase has been the industry pioneer having completed over 225,000 treatments and commanded numerous firsts within the industry, including;

  • The first laser eye treatment provider in the UK to have its treatment results independently verified, giving real transparency of results – a process which remains in place today.
  • The first and only company to ensure that all of its laser surgeons in GB are certified by the Royal College of Ophthalmologists; the highest specialist accreditation in this field.
  • Only national provider of Ultra Elite – the latest and most advanced wavefront treatment. Ultralase is pioneering Vue+ micro lens treatment giving it the widest range of presbyopic treatments of any national provider.
  • First laser eye specialist in Britain to offer a lifetime care guarantee.

For further information about Ultralase visit www.ultralase.com/info

Full year 2010 represents the year to 31 December 2010 for Ultralase Acquisition Limited and its subsidiaries

Ultralase is the UK's first laser eye surgery specialists, celebrating 20 years of 20:20 vision. In latest independently verified results, their highly qualified team of laser surgeons, all certified by the Royal College of Ophthalmologists, and state of the art technology, saw 99% of patients achieve 20/20 vision and 100% achieve driving standard vision*. Ultralase is also the only national UK laser eye specialist in Britain to offer a genuine lifetime care guarantee across its entire treatment range.

* All Ultra Elite treatment results, (excluding mono vision and partial treatments) July 13th to November 3rd 2009, Binocular vision.

Contact Information